ÂÜÀòÉç

Skip to main content

Treats Adults

Michael T Pulley, MD, PhD

Neurologist Clinical Neurophysiologist Neuromuscular Medicine Physician

Neurologist, Clinical Neurophysiologist, Neuromuscular Medicine Physician

4.6 /5 747 ratings
Photo of Michael T Pulley
(904) 383-1022

Research at a glance

Top areas of exploration

  • Myasthenia Gravis , 8 publications
  • Amyotrophic Lateral Sclerosis , 5 publications
  • Prednisone , 5 publications
  • Receptors, Cholinergic , 4 publications

Research activity

21 publications

812 citations

Why is this important?

My publications

21 publications

2025

Acute adenosine receptor antagonism in combination with acute intermittent hypoxia (AIH) to promote breathing plasticity in Amyotrophic lateral sclerosis: study protocol for a randomized, double-blinded, placebo-controlled trial (Preprint)

JMIR Research Protocols

2025

Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.

The Lancet. Neurology

•

2025

A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.

Muscle & nerve

•

2023

Primary lateral sclerosis natural history study - planning, designing, and early enrollment.

Amyotrophic lateral sclerosis & frontotemporal degeneration

•

2023

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.

Neurology

•